NCT07303907RecruitingPhase 2
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
An Open-label Study Evaluating DT402 in Adults With Autism Spectrum Disorder
Source: ClinicalTrials.gov · Last updated 2 Sept 2026
Brief summary (registry, in English)
A Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 22 Dec 2025
- Start date
- 3 Dec 2025
- Primary completion date
- Aug 2027
- Lead sponsor
- Definium Therapeutics US, Inc.
- Diseases
- Autism
- NCT number
- NCT07303907
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 20
- From 3 Dec 2025 to the primary completion date, Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- First degree relative with or lifetime history of a psychotic disorder or bipolar disorder
- Current diagnosis of alcohol or substance use disorder (excluding nicotine and caffeine)
- Any clinically significant unstable illness
Other
- Has uncorrected abnormalities in eye movement, alignment, or acuity or atypical eye features that could interfere with eye tracking
Who the study is looking for
- Diagnosis of ASD per records as confirmed by standard semi-structured interview for Autism diagnosis (eg, Autism Diagnostic Observation Schedule-Second Edition)
- Male or Female aged 18 to 65
- Presents with clinically significant deficits in socialization and communication as determined by Social Responsiveness Scales (SRS-2) ≥66
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Spectrum Neuroscience and Treatment Institute Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.